The estimated Net Worth of Richard A Gonzalez is at least $245 Milion dollars as of 5 August 2024. Mr. Gonzalez owns over 66,500 units of Abbvie Inc stock worth over $86,903,699 and over the last 22 years he sold ABBV stock worth over $136,292,321. In addition, he makes $21,610,600 as Chairman of the Board a Chief Executive Officer at Abbvie Inc.
Richard has made over 38 trades of the Abbvie Inc stock since 2003, according to the Form 4 filled with the SEC. Most recently he sold 66,500 units of ABBV stock worth $12,403,580 on 5 August 2024.
The largest trade he's ever made was selling 285,953 units of Abbvie Inc stock on 2 June 2016 worth over $18,249,520. On average, Richard trades about 42,541 units every 77 days since 2003. As of 5 August 2024 he still owns at least 446,599 units of Abbvie Inc stock.
You can see the complete history of Mr. Gonzalez stock trades at the bottom of the page.
Richard A. Gonzalez is the Chairman of the Board, Chief Executive Officer of the Company. Mr. Gonzalez is the chairman and chief executive officer of AbbVie. He served as Abbott's executive vice president of the pharmaceutical products group from July 2010 to December 2012, and was responsible for Abbott's worldwide pharmaceutical business, including commercial operations, research and development, and manufacturing. He also served as president, Abbott Ventures Inc., Abbott's medical technology investment arm, from 2009 to 2011. Mr. Gonzalez joined Abbott in 1977 and held various management positions before briefly retiring in 2007, including: Abbott's president and chief operating officer; president, chief operating officer of Abbott's Medical Products Group; senior vice president and president of Abbott's former Hospital Products Division; vice president and president of Abbott's Health Systems Division; and divisional vice president and general manager for Abbott's Diagnostics Operations in the United States and Canada. As a result of his service as Abbott's executive vice president, Pharmaceutical Products Group, his previous service as Abbott's president and chief operating officer and his more than 30-year career at Abbott, Mr. Gonzalez has developed valuable business, management and leadership experience, as well as extensive knowledge of AbbVie and its global operations. Mr. Gonzalez's experience and knowledge enable him to contribute to AbbVie's board key insights into strategic, management, and operational matters.
As the Chairman of the Board a Chief Executive Officer of Abbvie Inc, the total compensation of Richard Gonzalez at Abbvie Inc is $21,610,600. There are no executives at Abbvie Inc getting paid more.
Richard Gonzalez is 65, he's been the Chairman of the Board a Chief Executive Officer of Abbvie Inc since 2013. There are 7 older and 24 younger executives at Abbvie Inc. The oldest executive at Abbvie Inc is Edward Liddy, 73, who is the Independent Director.
Richard's mailing address filed with the SEC is North Waukegan Road, North Chicago, Lake County, Illinois, 60044, United States.
Over the last 12 years, insiders at Abbvie Inc have traded over $324,915,370 worth of Abbvie Inc stock and bought 214,015 units worth $14,446,494 . The most active insiders traders include Richard A Gonzalez, Frederick H Waddell a Glenn F Tilton. On average, Abbvie Inc executives and independent directors trade stock every 22 days with the average trade being worth of $7,529,855. The most recent stock trade was executed by Richard A Gonzalez on 5 August 2024, trading 66,500 units of ABBV stock currently worth $12,403,580.
AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. Their primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohns disease, plaque psoriasis, and ulcerative colitis.
Abbvie Inc executives and other stock owners filed with the SEC include: